Drupal.behaviors.print = function(context) {window.print();window.close();}>
Agilent Offering Senior Notes, Restates Earnings to Reflect Dako Purchase
September 10, 2012
Agilent Offering Senior Notes, Restates Earnings to Reflect Dako Purchase
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
M&A Deals in 'Omics Tools, MDx Space Drop 30 Percent in H1 2012
July 9, 2012 / GenomeWeb Daily News
Agilent Completes Acquisition of Dako
June 21, 2012 / GenomeWeb Daily News
Dako Deal to Provide Agilent with FDA Expertise, Company Official Says at Jefferies Conference
June 4, 2012 / GenomeWeb Daily News
Agilent Buying Cancer Diagnostics Company Dako for $2.2B
May 17, 2012 / GenomeWeb Daily News
FDA Approves Dako Assays as CDx for Genentech Breast Cancer Drug
March 5, 2013 / GenomeWeb Daily News